These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 7884514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow.
    Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA.
    Circulation; 1997 Oct 07; 96(7):2332-8. PubMed ID: 9337208
    [Abstract] [Full Text] [Related]

  • 3. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA.
    Circulation; 1995 Aug 15; 92(4):994-1004. PubMed ID: 7641384
    [Abstract] [Full Text] [Related]

  • 4. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity.
    Glover DK, Ruiz M, Edwards NC, Cunningham M, Simanis JP, Smith WH, Watson DD, Beller GA.
    Circulation; 1995 Feb 01; 91(3):813-20. PubMed ID: 7828310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model.
    Di Bella EV, Ross SG, Kadrmas DJ, Khare HS, Christian PE, McJames S, Gullberg AG.
    Invest Radiol; 2001 Mar 01; 36(3):178-85. PubMed ID: 11228582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA, Beller GA, Ruiz M, Yang JY, Watson DD, Glover DK.
    J Nucl Med; 1996 Aug 01; 37(8):1398-402. PubMed ID: 8708783
    [Abstract] [Full Text] [Related]

  • 9. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.
    Li QS, Solot G, Frank TL, Wagner HN, Becker LC.
    J Nucl Med; 1991 Oct 01; 32(10):1968-76. PubMed ID: 1919740
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.
    Stewart RE, Heyl B, O'Rourke RA, Blumhardt R, Miller DD.
    J Nucl Med; 1991 Oct 01; 32(10):2000-8. PubMed ID: 1919745
    [Abstract] [Full Text] [Related]

  • 11. Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole.
    Johnson G, Glover DK, Hebert CB, Okada RD.
    J Nucl Cardiol; 1994 Oct 01; 1(4):338-50. PubMed ID: 9420717
    [Abstract] [Full Text] [Related]

  • 12. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
    Abraham SA, Mirecki FN, Levine D, Nunn AD, Strauss HW, Gewirtz H.
    J Nucl Med; 1995 Jun 01; 36(6):1062-8. PubMed ID: 7769429
    [Abstract] [Full Text] [Related]

  • 13. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.
    Vanzetto G, Calnon DA, Ruiz M, Watson DD, Pasqualini R, Beller GA, Glover DK.
    Circulation; 1997 Oct 07; 96(7):2325-31. PubMed ID: 9337207
    [Abstract] [Full Text] [Related]

  • 14. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
    Di Rocco RJ, Rumsey WL, Kuczynski BL, Linder KE, Pirro JP, Narra RK, Nunn AD.
    J Nucl Med; 1992 Jun 07; 33(6):1152-9. PubMed ID: 1534576
    [Abstract] [Full Text] [Related]

  • 15. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H, Reinhardt CP, Leppo JA.
    J Nucl Med; 1993 Sep 07; 34(9):1510-7. PubMed ID: 8355072
    [Abstract] [Full Text] [Related]

  • 16. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
    Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M.
    J Am Coll Cardiol; 1992 Sep 07; 20(3):712-9. PubMed ID: 1512353
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
    Glover DK, Ruiz M, Koplan BA, Watson DD, Beller GA.
    J Nucl Med; 1999 Jan 07; 40(1):142-9. PubMed ID: 9935070
    [Abstract] [Full Text] [Related]

  • 18. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
    Iskandrian AS, Heo J, Nguyen T, Beer S, Cave V, Cassel D, Iskandrian BB.
    J Am Coll Cardiol; 1992 Feb 07; 19(2):307-12. PubMed ID: 1732357
    [Abstract] [Full Text] [Related]

  • 19. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
    Marshall RC, Leidholdt EM, Zhang DY, Barnett CA.
    J Nucl Med; 1991 Oct 07; 32(10):1979-88. PubMed ID: 1919742
    [Abstract] [Full Text] [Related]

  • 20. Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole: differentiation of stenosis severity in canine myocardium.
    Johnson G, Glover DK, Hebert CB, Okada RD.
    J Nucl Med; 1995 Jan 07; 36(1):111-9. PubMed ID: 7799062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.